ICH seeks independence from innovator industry funds, more members and legal status
This article was originally published in SRA
The International Conference on Harmonisation is exploring alternative funding models with a view to being less dependent on the innovator drug industry as the major source of its financial support.
You may also be interested in...
Health technology assessment body NICE wants Kite to collect more evidence to prove that Tecartus can cure relapsed or refractory mantle cell lymphoma. But in the meantime, it says the CAR-T therapy should be made available on the National Health Service, making UK patients among the first in the world to be offered access to the treatment.
New medicines under evaluation at the European Medicines Agency.
The latest list of marketing authorization applications under review by the European Medicines Agency includes filings for eight new products.